The clinical efficiency of positive airway pressure (PAP) treatment in patients with moderate-severe obstructive sleep apnea syndrome (OSAS)

A study evaluating the clinical efficiency and compliance of positive airway pressure (PAP) treatment on patients with moderate-severe obstructive sleep apnea syndroma (OSAS)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12613000373774

Enrollment

Registered

2013-04-08

Start date

2008-01-01

Completion date

2011-04-01

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Objectives: The aim of this study was to evaluate the clinical efficiency and compliance of positive airway pressure treatment. Materials&Methods: This study was conducted on moderate-severe obstuctive sleep apnea syndrome (OSAS) patients who admitted to Ankara Numune Hospital Sleep Center between 2008 and 2012. Seventy five patients with moderate-severe OSAS who were using PAP treatment regularly were enrolled to study. Patient’s usage data, Epworth sleepiness scale (ESS) scores and the differences in complaints of OSAS were recorded. Results: The overall complaints were improved when compared to pretreatment period. Particularly there was improvement in apnea, snoring, excessive daytime sleepiness, fatigue and sleep quality. Conclusion: PAP is effective in reducing symptoms in people with moderate and severe OSAS. To inform the patients in details and creation of strategies for close follow up are necessary for improving the compliance of the patients.

Interventions

Arm 1: device (In moderate-severe OSAS patients main treatment is positive airway pressure (PAP) device. We have investigated the efficiancy of this device.) In obstructive sleep apnea patients the saturation of oxygen level are under normal level. In some patients we measure that about 30-40% PAP device positive pressure. Low oxygen levels are associated with chronic disease as myocardial infarction. When apnea appears in patients and saturation of the oxygen level decreases PAP device improve

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

Obstruvtive Sleep Apnea patients with AHI>5 (apnea hypopnea index)

Exclusion criteria

AHI<5 (apnea hypopnea index)

Outcome results